Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study)
Latest Information Update: 15 Dec 2023
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; Tozinameran (Primary) ; Aluminium hydroxide
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Acronyms Cobovax
- 08 Dec 2023 Planned End Date changed from 31 Mar 2024 to 31 Dec 2025.
- 08 Dec 2023 Planned primary completion date changed from 31 Mar 2023 to 31 Dec 2024.
- 08 Feb 2022 Status changed from recruiting to active, no longer recruiting.